Alivus Life Sciences Limited

ALIVUSFair value region

A 6-pillar fundamental profile. Each pillar scored 0–10.

5.4/10 composite
Prism for ALIVUS.NS: composite 5.4 of 10, verdict Fair value regionPULSEQUALITYMOATSAFETYGROWTHVALUE0.00.00.00.00.00.0

Pulse

9.0 · Positive

Analyst revision trend (fallback)

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means stronger near-term tailwinds.

Quality

7.4 · Moderate

Piotroski 7/9, ROCE 22.3%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

6.5 · Moderate

Narrow moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

7.0 · Moderate

Int cov 272.4x

Safety looks at balance-sheet strength, leverage, and cash generation. Higher means lower financial risk.

Growth

1.1 · Weak

Rev CAGR 3.3%, EPS CAGR -52.7%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

3.9 · Weak

MoS 0%, P/E 23.8

Value measures whether the stock is cheap relative to its intrinsic worth. Higher is cheaper.

Compare with another stock

Overlay ALIVUS's prism against a peer.

Share this prism

Share on XWhatsApp

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for ALIVUS.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.